<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>Science and Education Publishing</PublisherName>
<JournalTitle>Journal of Food and Nutrition Research</JournalTitle>
<Issn>2333-1240</Issn>
<Volume>3</Volume>
<Issue>6</Issue>
<PubDate PubStatus="epublish">
<Year>2015</Year>
<Month>07</Month>
<Day>05</Day>
</PubDate>
</Journal>
<ArticleTitle>Nitric Oxide and Inflammatory Cytokine Productions in Diabetic Rats Supplemented with Goat Milk and Soy Milk Kefir</ArticleTitle>
<FirstPage>384</FirstPage>
<LastPage>391</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName></FirstName>
<LastName>Nurliyani</LastName>
<Affiliation>Department of Animal Product Technology, Faculty of Animal Science, Universitas Gadjah Mada, Jl. Fauna 3 Kampus UGM, Bulaksumur, Yogyakarta 55281, Indonesia</Affiliation>
</Author>
<Author>
<FirstName>Eni</FirstName>
<LastName>Harmayani</LastName>
</Author>
<Author>
<FirstName></FirstName>
<LastName>Sunarti</LastName>
</Author>

</AuthorList>
<ArticleIdList>
<ArticleId IdType="pii">JFNR2015365</ArticleId>
<ArticleId IdType="doi">10.12691/jfnr-3-6-5</ArticleId>
</ArticleIdList>
<History>
<PubDate PubStatus="received">
<Year>2015</Year>
<Month>06</Month>
<Day>09</Day>
</PubDate>
<PubDate PubStatus="revised">
<Year>2015</Year>
<Month>06</Month>
<Day>23</Day>
</PubDate>
<PubDate PubStatus="accepted">
<Year>2015</Year>
<Month>07</Month>
<Day>05</Day>
</PubDate>
</History>
<Abstract>Diabetes has been known as an inflammatory diseases, and the certain of probiotics when administered in adequate amounts were reported have an anti-inflammatory properties. The purpose of this study were to evaluate the effect of administration of goat milk and soy milk kefir on immune responses including spleen lymphocyte proliferation, production of pro-inflammatory cytokine (TNF-α) and anti-inflammatory cytokine (IL-10), as well as  peritoneal macrophage nitric oxide (NO) production in diabetic rats induced with streptozotocin-nicotinamide. Male Wistar rats were divided into five groups: negative control, positive control, diabetic rats fed goat milk kefir, diabetic rats fed kefir combination from goat milk and soy milk kefir and diabetic rats fed soy milk kefir. After 5 weeks  treatment, the rats were sacrificed and sampled for spleen and peritoneal macrophages. The results showed that kefir combination from goat milk and soy milk kefir could increase lymphocyte proliferation and IL-10 production, as well as decreased TNF-α significantly (p&lt;0.05) in diabetic rats. However, the effect of kefir combination showed  the lowest NO production in diabetic rats compared with goat milk kefir and soy milk kefir.   In conclusion, kefir combination from goat milk and soy milk may be used as biotherapeutic for type-2 diabetes mellitus by improving systemic immune responses through  increasing in lympocyte proliferation and IL-10 as well as decreasing in TNF-α production.</Abstract>
</Article>
</ArticleSet>
